Insights / October 16, 2019 / by beaconlbs

Featured Lab-Of-Choice: GeneDx

BeaconLBS has invited the Labs-of-Choice™ to provide some more information about themselves for a blog series featuring each of the Labs-of-Choice. The following content was provided by the featured lab, GeneDx.

Company Description: Rare Genetics Laboratory

GeneDx was founded in 2000 by two scientists from the National Institutes of Health (NIH) to diagnose patients with rare disorders and assist clinicians responsible for treating these patients. GeneDx has become a global industry leader in genetics and genomics, having provided testing to patients and their families in over 55 countries.

Led by its clinical genomics program, and a comprehensive genetic testing menu, GeneDx offers genetic testing for hereditary cancers, cardiac, mitochondrial, rare and neurological disorders, prenatal diagnostics, and targeted variant testing. To date, GeneDx has performed over 150,000 exomes. www.genedx.com

You Might Also Like:

Molecular Genetics / June 11, 2019 / by beaconlbs

Liquid Biopsy in Cancer Diagnosis, Detection and Treatment

Recently, there has been much excitement about the potential for liquid biopsy’s possible applications in cancer detection, diagnosis, and treatment. Learn more about the current evidence of clinical utility of cell free DNA in our latest blog.

Helpful Tools / January 14, 2019 / by beaconlbs

The Use Of PREMM5 In Identifying Risk Of Having Lynch Syndrome

Learn about the PREMM5 tool below and how it can help you determine if your patient needs Lynch syndrome testing.